Robeco Institutional Asset Management B.V.
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1418773
ROTTERDAM, P7
Position in ADPT
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$0
+$0 QoQ
Shares Held
2,913
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $752,223,267 across 11 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
577,627 | $289,599,072 | |
| 2 | NTRA |
Natera, Inc.
|
408,616 | $110,918,813 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
172,393 | $90,754,570 | |
| 4 | DHR |
Danaher Corp /De/
|
414,716 | $78,995,103 | |
| 5 | ILMN |
Illumina, Inc.
|
307,785 | $54,117,836 | |
| 6 | A |
Agilent Technologies, Inc.
|
294,273 | $39,088,282 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
175,465 | $33,903,347 | |
| 8 | DGX |
Quest Diagnostics Inc
|
112,546 | $23,854,124 |
All Filings in ADPT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 11,652 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | — | 11,652 | Shares | Defined | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||